본문 바로가기
KERD
논문KCI 등재

How lessons learned from the 2015 Middle East respiratory syndrome outbreak affected the response to coronavirus disease 2019 in the Republic of Korea

2

조회

0

다운로드

3

인용

0

참고문헌

키워드

주제분류내과학

초록

The Republic of Korea (ROK) experienced a public health crisis due to Middle East respiratory syndrome (MERS) in 2015 and is currently going through the coronavirus disease 2019 (COVID-19) pandemic. Lessons learned from the disastrous MERS outbreak were ref lected in the preparedness system, and the readiness capabilities that were subsequently developed enabled the country to successfully flatten the epidemic curve of COVID-19 in late February and March 2020. In this review, we summarize and compare the epidemiology and response of the ROK to the 2015 MERS outbreak and the COVID-19 epidemic in early 2020. We emphasize that, because further COVID-19 waves seem inevitable, it is urgent to develop comprehensive preparedness and response plans for the worst-case scenarios of the COVID-19 pandemic. Simultaneously strengthening healthcare capacity to endure the peak demand and implementing smart strategies to sustain social distancing and public hygiene are necessary until safe and effective therapeutics and vaccines against COVID-19 are available.

Abstract

The Republic of Korea (ROK) experienced a public health crisis due to Middle East respiratory syndrome (MERS) in 2015 and is currently going through the coronavirus disease 2019 (COVID-19) pandemic. Lessons learned from the disastrous MERS outbreak were ref lected in the preparedness system, and the readiness capabilities that were subsequently developed enabled the country to successfully flatten the epidemic curve of COVID-19 in late February and March 2020. In this review, we summarize and compare the epidemiology and response of the ROK to the 2015 MERS outbreak and the COVID-19 epidemic in early 2020. We emphasize that, because further COVID-19 waves seem inevitable, it is urgent to develop comprehensive preparedness and response plans for the worst-case scenarios of the COVID-19 pandemic. Simultaneously strengthening healthcare capacity to endure the peak demand and implementing smart strategies to sustain social distancing and public hygiene are necessary until safe and effective therapeutics and vaccines against COVID-19 are available.

참고문헌 (88)

  1. "BMJ Best Practice: coronavirus disease 2019(COVID-19)" (2020)[URL]
  2. Memish ZA, "Middle East respiratory syndrome", Lancet, 395, pp.1063~1077 (2020)
  3. Frieden TR, "Identifying and interrupting superspreading events : implications for control of severe acute respiratory syndrome coronavirus 2", Emerg Infect Dis, 26, pp.1059~1066 (2020)
  4. "WHO Scientific Advisory Group of the research and development blueprint:February 2017 update" (2017)[URL]
  5. "R&D Bblueprint and COVID-19" (2020)[URL]
  6. Hoffmann M, "SARSCoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor", Cell, 181, pp.271~280 (2020)
  7. Letko M, "Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses", Nat Microbiol, 5, pp.562~569 (2020)
  8. Li R, "Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus(SARS-CoV-2)", Science, 368, pp.489~493 (2020)
  9. Nishiura H, "Serial interval of novel coronavirus(COVID-19)infections", Int J Infect Dis, 93, pp.284~286 (2020)
  10. "Global COVID-19 case fatality rates" (2020)[URL]
  11. Park JE, "MERS transmission and risk factors : a systematic review", BMC Public Health, 18, pp.574~ (2018)
  12. Park WB, "Replicative virus shedding in the respiratory tract of patients with Middle East respiratory syndrome coronavirus infection", Int J Infect Dis, 72, pp.8~10 (2018)
  13. Raj VS, "Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC", Nature, 495, pp.251~254 (2013)
  14. Vetter P, "Clinical features of covid-19", BMJ, 369, pp.m1470~ (2020)
  15. Wolfel R, "Virological assessment of hospitalized patients with COVID-2019", Nature, 581, pp.465~469 (2020)
  16. "Middle East respiratory syndrome coronavirus (MERS-CoV)" (2019)[URL]
  17. "Laboratory testing for Middle East respiratory syndrome coronavirus: interim guidance (revised)" (2018)[URL]
  18. "Molecular assays to diagnose COVID-19: Summary table of available protocols" (2020)[URL]
  19. Cheng HY, "Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset", JAMA Intern Med, 180, pp.1156~1163 (2020)
  20. "Middle East respiratory syndrome coronavirus (MERS-CoV)" (2020)[URL]
  21. The 2015 MERS Outbreak in the Republic of Korea: Learning from MERS, "Ministry of Health and Welfare", MOHW, ~ (2016)
  22. "COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE)" (2020)[URL]
  23. Korea Centers for Disease Control and Prevention, "Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, 2015", Osong Public Health and Research Perspectives, 6(4), pp.269~278 (2015), 질병관리청
  24. "Socioeconomic impact of emerging infectious diseases and effect of social investments on emerging infectious disease response, 2020" (2020)[URL]
  25. 강창경, "Clinical and Epidemiologic Characteristics of Spreaders of Middle East Respiratory Syndrome Coronavirus during the 2015 Outbreak in Korea", Journal of Korean Medical Science, 32(5), pp.744~749 (2017), 대한의학회
  26. Kim SW, "Risk factors for transmission of Middle East respiratory syndrome coronavirus infection during the 2015 outbreak in South Korea", Clin Infect Dis, 64, pp.551~557 (2017)
  27. Bernard-Stoecklin S, "Comparative analysis of eleven healthcare-associated outbreaks of Middle East respiratory syndrome coronavirus(MERSCoV)from 2015 to 2017", Sci Rep, 9, pp.7385~ (2019)
  28. Kucharski AJ, "The role of superspreading in Middle East respiratory syndrome coronavirus(MERSCoV)transmission", Euro Surveill, 20, pp.14~18 (2015)
  29. Jang K, "The effects of repetitive information communication through multiple channels on prevention behavior during the 2015 MERS outbreak in South Korea", J Health Commun, 23, pp.670~678 (2018)
  30. Jang WM, "Preventive behavioral responses to the 2015 Middle East respiratory syndrome coronavirus outbreak in Korea", Int J Environ Res Public Health, 16, pp.2161~ (2019)
  31. 장원모, "Social Distancing and Transmission-reducing Practices during the 2019 Coronavirus Disease and 2015 Middle East Respiratory Syndrome Coronavirus Outbreaks in Korea", Journal of Korean Medical Science, 35(23), pp.1~11 (2020), 대한의학회[DOI]
  32. 정갑용, "MERS 발생 후 손 위생 및 개인보호장구에 대한 응급실 근무자들의 효과성 인식 및 수행률 조사", 대한응급의학회지, 27(4), pp.328~335 (2016), 대한응급의학회
  33. KSID White Paper on Chronicles of MERS, "Korea Society of Infectious Diseases", Korea Society of Infectious Diseases, ~ (2015)
  34. Yushim Kim, "Interorganizational Coordination and Collaboration During the 2015 MERS-CoV Response in South Korea", Disaster Medicine and Public Health Preparedness, 15(4), pp.409~415 (2021), Cambridge University Press (CUP)[DOI]
  35. Kim K, "Dynamics of interorganizational public health emergency management networks : following the 2015 MERS response in South Korea", Asia Pac J Public Health, 30, pp.207~216 (2018)
  36. "WHO statement on the ninth meeting of the IHR Emergency Committee regarding MERS-CoV" (2015)[URL]
  37. Shin N, "Effects of operational decisions on the diffusion of epidemic disease : a system dynamics modeling of the MERS-CoV outbreak in South Korea", J Theor Biol, 421, pp.39~50 (2017)
  38. "MERS tarnishes Korean President’s image as leader" (2015)[URL]
  39. 최재욱, "공중보건 위기관리 대응과 소통체계 구축: 중동호흡기증후군 사태의 경험과 교훈", 대한의사협회지, 58(7), pp.624~634 (2015), 대한의사협회[DOI]
  40. Kim EY, "Middle East respiratory syndrome in South Korea during 2015 : risk-related perceptions and quarantine attitudes", Am J Infect Control, 44, pp.1414~1416 (2016)
  41. 이순영, "Preventive behaviors by the level of perceived infection sensitivity during the Korea outbreak of Middle East Respiratory Syndrome in 2015", Epidemiology and Health, 38, pp.1~10 (2016), 한국역학회[DOI]
  42. 김옥주, "Ethical Perspectives on the Middle East Respiratory Syndrome Coronavirus Epidemic in Korea", 예방의학회지, 49(1), pp.18~22 (2016), 대한예방의학회
  43. "Progress on plans for reform of the national infectious disease prevention and management system" (2016)[URL]
  44. "This is how they made it in S. Korea, Large-Scale Diagnostic Tests" (2020)[URL]
  45. 성문우, "External Quality Assessment of MERS-CoV Molecular Diagnostics During the 2015 Korean Outbreak", Annals of Laboratory Medicine, 36(3), pp.230~234 (2016), 대한진단검사의학회
  46. The 2018 MERS Response in the Republic of Korea, "Korea Centers for Disease Control and Prevention", Korea Centers for Disease Control and Prevention, ~ (2019)
  47. Lee JY, "A Middle East respiratory syndrome screening clinic for health care personnel during the 2015 Middle East respiratory syndrome outbreak in South Korea : a single-center experience", Am J Infect Control, 46, pp.436~440 (2018)
  48. 전민혁, "Institutional Preparedness to Prevent Future Middle East Respiratory Syndrome Coronavirus-Like Outbreaks in Republic of Korea", Infection and Chemotherapy, 48(2), pp.75~80 (2016), 대한감염학회
  49. 김진용, "Middle East Respiratory Syndrome Infection Control and Prevention Guideline for Healthcare Facilities", Infection and Chemotherapy, 47(4), pp.278~302 (2015), 대한감염학회
  50. Noh JW, "Effect of information disclosure policy on control of infectious disease : MERS-CoV outbreak in South Korea", Int J Environ Res Public Health, 17, pp.305~ (2020)
  51. Park S, "Information technology-based tracing strategy in response to COVID-19 in South Korea:privacy controversies", JAMA, 323, pp.2129~2130 (2020)
  52. "Joint external evaluation of IHR cope capacities of the Republic of Korea: mission report" (2018)[URL]
  53. "COVID-19 dashboard" (2020)[URL]
  54. Korean Society of Infectious Diseases, "Report on the Epidemiological Features of Coronavirus Disease 2019 (COVID-19) Outbreak in the Republic of Korea from January 19 to March 2, 2020", Journal of Korean Medical Science, 35(10), pp.1~11 (2020), 대한의학회[DOI]
  55. Jang S, "Cluster of coronavirus disease associated with fitness dance classes, South Korea", Emerg Infect Dis, 26, pp.1917~1920 (2020)
  56. Park SY, "Coronavirus disease outbreak in call center, South Korea", Emerg Infect Dis, 26, pp.1666~1670 (2020)
  57. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, "The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2", Nat Microbiol, 5, pp.536~544 (2020)
  58. Ge XY, "Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor", Nature, 503, pp.535~538 (2013)
  59. Lau SK, "Ecoepidemiology and complete genome comparison of different strains of severe acute respiratory syndrome-related Rhinolophus bat coronavirus in China reveal bats as a reservoir for acute, self-limiting infection that allows recombination events", J Virol, 84, pp.2808~2819 (2010)
  60. Wang C, "A novel coronavirus outbreak of global health concern", Lancet, 395, pp.470~473 (2020)
  61. Burke RM, "Active monitoring of persons exposed to patients with confirmed COVID-19 : United States, January-February 2020", MMWR Morb Mortal Wkly Rep, 69, pp.245~246 (2020)
  62. Chan JF, "A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission : a study of a family cluster", Lancet, 395, pp.514~523 (2020)
  63. "Coronavirus disease 2019(COVID-19): situation report, 73. 2020" (2020)[URL]
  64. "Infection prevention and control during health care when novel coronavirus (nCoV)infection is suspected: interim guidance" (2020)[URL]
  65. Lauer SA, "The incubation period of coronavirus disease 2019(COVID-19)from publicly reported confirmed cases : estimation and application", Ann Intern Med, 172, pp.577~582 (2020)
  66. Kahn R, "Incubation periods impact the spatial predictability of cholera and Ebola outbreaks in Sierra Leone", Proc Natl Acad Sci U S A, 117, pp.5067~5073 (2020)
  67. Oran DP, "Prevalence of asymptomatic SARSCoV-2 infection : a narrative review", Ann Intern Med, 173, pp.362~367 (2020)
  68. "WHO coronavirus disease (COVID-19) dashboard" (2020)[URL]
  69. Matrajt L, "Evaluating the effectiveness of social distancing interventions to delay or flatten the epidemic curve of coronavirus disease", Emerg Infect Dis, 26, pp.1740~1748 (2020)
  70. "Korean government’s response system (as of February 25, 2020)" (2020)[URL]
  71. "Update of COVID-19 in Korea as of 30 January 2020" (2020)[URL]
  72. Sang Il Kim, "Walk-Through Screening Center for COVID-19: an Accessible and Efficient Screening System in a Pandemic Situation", Journal of Korean Medical Science, 35(15), pp.1~8 (2020), 대한의학회[DOI]
  73. Ki Tae Kwon, "Drive-Through Screening Center for COVID-19: a Safe and Efficient Screening System against Massive Community Outbreak", Journal of Korean Medical Science, 35(11), pp.1~4 (2020), 대한의학회[DOI]
  74. COVID-19 National Emergency Response Center, "Contact Transmission of COVID-19 in South Korea: Novel Investigation Techniques for Tracing Contacts", Osong Public Health and Research Perspectives, 11(1), pp.60~63 (2020), 질병관리청[DOI]
  75. Her M, "Repurposing and reshaping of hospitals during the COVID-19 outbreak in South Korea", One Health, 10, pp.100137~ (2020)
  76. COVID-19 Hospital Infection Prevention and Control, "Korea Centers for Disease Control and Prevention", Korea Centers for Disease Control and Prevention, ~ (2020)
  77. "Severe acute respiratory syndrome (SARS)" (2020)[URL]
  78. Kissler SM, "Projecting the transmission dynamics of SARS-CoV-2through the postpandemic period", Science, 368, pp.860~868 (2020)
  79. "COVID-19: the CIDRAP Viewpoint" (2020)[URL]
  80. 김탁, "Improving Preparedness for and Response to Coronavirus Disease 19 (COVID-19) in Long-Term Care Hospitals in Korea", Infection and Chemotherapy, 52(2), pp.133~141 (2020), 대한감염학회[DOI]
  81. "Victims of infodemic" (2020)[URL]
  82. "KT gets Bill & Melinda Gates Foundation’s W12b funding for epidemic research" (2020)[URL]
  83. Li H, "Updated approaches against SARS-CoV-2", Antimicrob Agents Chemother, 64, pp.e00483~20 (2020)
  84. "Accelerating a safe and effective COVID-19 vaccine" (2020)[URL]
  85. Thanh Le T, "The COVID-19 vaccine development landscape", Nat Rev Drug Discov, 19, pp.305~306 (2020)
  86. "Adverse consequences of school closures" (2020)[URL]
  87. Bayham J, "Impact of school closures for COVID-19 on the US health-care workforce and net mortality : a modelling study", Lancet Public Health, 5, pp.e271~e278 (2020)
  88. Munro APS, "Children are not COVID-19 super spreaders : time to go back to school", Arch Dis Child, 105, pp.618~619 (2020)

관련 논문AI추천

Institutional Preparedness to Prevent Future Middle East Respiratory Syndrome Coronavirus-Like Outbreaks in Republic of Korea김태형, 전민혁대한감염학회 · Infection and Chemotherapy2016 · 제48권 제2호The Same Middle East Respiratory Syndrome- Coronavirus (MERS-CoV) yet Different Outbreak Patterns and Public Health Impacts on the Far East Expert Opinion from the Rapid Response Team of the Republic of Korea대한감염학회, 대한의료관련감염관리학회대한감염학회 · Infection and Chemotherapy2015 · 제47권 제4호Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea송경호, Eu Suk Kim, Hong Bin Kim, Ji Hwan Bang, Myoung-don Oh, Nam Joong Kim, Pyoeng Gyun Choe, Sang-Won Park, Wan Beom Park대한내과학회 · The Korean Journal of Internal Medicine2018 · 제33권 제2호Strategical Preparedness and Response Actions in the Healthcare System Against Coronavirus Disease 2019 according to Transmission Scenario in Korea이재갑, Choi Min Joo, Kim Jin Yong, Kim Sun Bean, Kim Tark, Lee Heeyoung, Oh Hong Sang, Yoon Young Kyung대한감염학회 · Infection and Chemotherapy2020 · 제52권 제3호Interim Evaluation of South Korea’s Response to COVID-19 and Preparation for a Post-COVID-19 World in Public Health지영미서울대학교행정대학원 · Journal of Policy Studies2020 · 제35권 제3호2015년 한국의 중동호흡기증후군 유행 역학과 정책 과제이무식한국보건교육건강증진학회 · 보건교육건강증진학회지2015 · 제32권 제3호

이 간행물의 다른 논문 (28건)